The changing epidemiology of pulmonary hypertension: disease characteristics and clinical outcome over two decades of the swiss registry

P. Appenzeller (Zürich, Switzerland), M. Lichtblau (Zürich, Switzerland), C. Berlier (Zürich, Switzerland), J. Aubert (Lausanne, Switzerland), A. Azzola (Lucerne, Switzerland), J. Fellrath (Neuenburg, Switzerland), T. Geiser (Bern, Switzerland), F. Lador (Geneva, Switzerland), S. Pohle (St. Gallen, Switzerland), I. Opitz (Zurich, Switzerland), M. Schwerzmann (Bern, Switzerland), H. Stricker (Locarno, Switzerland), M. Tamm (Basel, Switzerland), S. Saxer (Zurich, Switzerland), S. Ulrich (Zurich, Switzerland)

Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Session: Pulmonary hypertension in the COVID-19 pandemic and beyond
Session type: E-poster
Number: 3594

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Appenzeller (Zürich, Switzerland), M. Lichtblau (Zürich, Switzerland), C. Berlier (Zürich, Switzerland), J. Aubert (Lausanne, Switzerland), A. Azzola (Lucerne, Switzerland), J. Fellrath (Neuenburg, Switzerland), T. Geiser (Bern, Switzerland), F. Lador (Geneva, Switzerland), S. Pohle (St. Gallen, Switzerland), I. Opitz (Zurich, Switzerland), M. Schwerzmann (Bern, Switzerland), H. Stricker (Locarno, Switzerland), M. Tamm (Basel, Switzerland), S. Saxer (Zurich, Switzerland), S. Ulrich (Zurich, Switzerland). The changing epidemiology of pulmonary hypertension: disease characteristics and clinical outcome over two decades of the swiss registry. 3594

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007



Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
Source: Eur Respir J 2016; 47: 388-389
Year: 2016


Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018


Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs
Source: Eur Respir Rev 2009; 18: 18-23
Year: 2009


Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice
Source: Eur Respir J 2013; 41: 1252-1256
Year: 2013



Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019
Year: 2020



A registry of patients with idiopathic pulmonary fibrosis in Russia: 2-yr results and therapeutic modalities in real-life practice
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019


An international survey on genetics in clinical practice for interstitial lung disease.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice
Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017
Year: 2017



Underrepresentation of patients with cardiovascular diseases in trials of chronic obstructive pulmonary disease: Transferability problems in general practice?
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Source: ERJ Open Res, 7 (2) 00046-2021; 10.1183/23120541.00046-2021
Year: 2021



New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension
Source: Eur Respir Rev 2013; 22: 495-502
Year: 2013



Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019

Bosentan treatment for pulmonary arterial hypertension related to congenital heart disease: real-world clinical experience in Spain
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

The disease model: implications for clinical practice
Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018
Year: 2018



Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry
Source: Eur Respir J, 53 (2) 1801677; 10.1183/13993003.01677-2018
Year: 2019



Clinical characteristics of pulmonary arterial hypertension in Ireland: results of a national register
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008